Astronics 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Third-quarter sales reached a record $271.7 million, up 28.5% from the prior-year period, and adjusted operating income was $51 million, or 18.8% of sales.
- Adjusted EBITDA increased over 81% to $59.3 million, with an adjusted EBITDA margin of 21.8%, compared with 15.5% a year earlier and 19.8% in the trailing second quarter.
- Net income was $52.2 million, or $1.08 per diluted share, compared with a net loss of $11.1 million, or $0.26 per diluted share, in the prior-year quarter; adjusted net income was $38.9 million, or $0.81 per diluted share.
- Gross profit increased 46% to $94 million, or 34.6% of sales; the 410 basis point expansion included 70 basis points from $1.9 million in tariff refunds.
- Consolidated bookings were $271.1 million, for a book-to-bill ratio of 1 to 1, and backlog ended the quarter at $780 million, roughly even with the record second quarter.
- Aerospace sales were a record $245.5 million, up 27.4%, and adjusted operating margin reached 22.5%; aerospace backlog was a record $670 million.
- Test Systems sales were $26.2 million, up 40%, and operating profit was $3.9 million, or 14.7% of sales; the U.S. Army 4549T radio test program contributed $5.3 million.
- Year-to-date sales were $762 million, up 22%; operating income was 16% of sales, compared with 6% last year, and adjusted EBITDA was $149 million, or 19.5% of sales, compared with 14.3% last year.
- Cash from operations was $25.8 million in the quarter; long-term debt decreased to $284.8 million, and quarter-end available liquidity was $278 million.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Greetings, and welcome to the Astronics Corporation Third Quarter Fiscal Year 2026 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce Deborah Pawlowski, Investor Relations for Astronics.
Please go ahead. Thank you, and good afternoon, everyone.
We appreciate your time today and your interest in Astronics. Joining me on the call are Peter Gundermann, our Chairman, President, CEO, and Nancy Hedges, our Chief Financial Officer. You should have a copy of our third quarter 2026 financial results, which crossed the wires after the market closed today. If you do not have the release, you can find it on our website at astronics.com. As you are likely aware, we may make some forward-looking statements during the formal discussion and the Q&A session of this conference call. These statements apply to future events that are subject to risks and uncertainties, as well as other factors that could cause actual results to differ materially from what is stated here today.
These risks and uncertainties and other factors are provided in the earnings release, as well as with other documents filed with the Securities and Exchange Commission. You can find those documents on our website as well, or at sec.gov. During today's call, we will have some non-GAAP measures that we will discuss. We believe these will be useful in evaluating our performance. You should not consider the presentation of this additional information in isolation or as a substitute for GAAP results. We have provided reconciliations of non-GAAP measures with comparable GAAP measures in the tables that accompany today's release. With that, I will turn it over to Pete to begin.
Pete? Hello, everybody, and welcome to the call.
We are here to talk about our third quarter results and our outlook for the remainder of the year. We will also take an early peek at 2027. Nancy and I will do our usual back and forth and then open up the lines for questions. In summary, the third quarter was very strong for Astronics. We set another record for quarterly sales, driven by the record bookings and backlog we achieved in the previous quarter. The strong top line played well on the bottom line. Adjusted operating income was 18.8% of sales, and adjusted EBITDA was 21.8% of sales. Both of these measures have improved significantly over the course of the year. Both of our segments contributed to the result. Our aerospace business had record sales of $245 million, continuing the positive trend it has maintained since the depths of COVID.
In addition to record sales, our aerospace segment ended the quarter with record backlog, so the indications are that the growth trend should continue. Our test segment also had a very positive quarter. Sales of $26 million were the highest since 2019, and positive operating income of 14.7% shows the benefit of the cost cutting we have accomplished in that business over the last year. Our test business also benefited from $5.3 million of sales related to the U.S. Army radio test program known as TS-4549/T, which is ramping and will approximately double that quarterly rate by the time we reach full-rate production in early 2027. We expect the improvement to continue in our test business as we go forward. Looking briefly at year-to-date results, the first three quarters of 2026 were very strong, showing high market demand for our products and services.
The strong demand drove record backlogs and is now driving strong financial bottom line results. Year-to-date sales of $762 million are up 22% over the previous year. Year-to-date operating income is 16% through three quarters compared to 6.6% last year, and adjusted EBITDA is $149 million, or 19.5% of sales compared to 14.3% of sales last year. In recent calls, I have spent time describing the sources of demand that are driving our business and can report today that they remain in force. Briefly, these demand drivers include, first, increasing aircraft build rates. Second, increasing adoption of high-level inflight entertainment & connectivity systems driven by strong passenger demand. Three, increased penetration of advanced flight-critical electrical power systems that we provide for small and medium-sized aircraft. Four, the trend towards premium aircraft seating that uses our seat motion systems.
And five, the ramp that is currently underway in our test business that I just mentioned related to our U.S. Army radio test program, TS-4549/T. These growth drivers cover our business comprehensively and remain very much in force. They have driven us to 22% growth so far in 2026 and an average of 18% annual growth since 2022. In our last call, we also talked about certain levers that we are using to improve our margin profile. Again, I'm not going to review them in detail, but briefly, they were, number one, the increased leverage that comes with higher sales volume. Two, repricing of long-term contracts that come due to cover the inflation that we have seen in recent years. Three, improved productivity and efficiency as our workforce stabilizes from the disruption associated with the pandemic.
And four, certain simplification or portfolio-shaping initiatives we have undertaken to sharpen the focus of our business and lower the cost of running it. All of these margin levers have been valuable, and we continue to work all of them. And the good news is that we feel each of them has room to run. I don't have any significant new announcements regarding them to make today, but know that under the surface, we continue to work these profitability levers, and there is more to be gained. The cumulative effect of these margin levers on our financial performance has been dramatic. As I mentioned moments ago, our operating margin year-to-date has climbed from 6.6% last year to 16% so far this year, and our adjusted EBITDA margin has risen from 14.3% last year to 19.5% this year.
In the third quarter, our adjusted EBITDA was just shy of 22%, our highest level in many years. We feel we are in a good place. Demand for our products is strong, and we have demonstrated the ability to convert that demand into an improved bottom line. We feel like we are in a good spot. With that being said, I will turn it over to Nancy to review the Q3 accounting details.
Nancy? Thanks, Pete, and good afternoon, everyone.
I will walk through our third quarter results in more detail, provide color on our product lines and our segments, and review cash flow and the balance sheet. As Pete noted, we delivered another strong quarter with record sales and operating income and further improvement in profitability across both segments. Sales reached $271.7 million, up 28.5% from the prior year period. Higher volume and improved productivity continue to drive margin expansion, while Test Systems made meaningful progress as production on the US Army radio test program advanced. Gross profit increased 46% to $94 million, or 34.6% of sales. In addition to the impact of volume and better productivity, the 410 basis point expansion benefited from $1.9 million in tariff refunds recognized during the quarter, which contributed 70 basis points. R&D expense decreased $900,000 due to the timing of projects.
We expect R&D to normalize in the near future in a range of 4%-5% of sales. SG&A expense was $30.7 million, down approximately half a million dollars year-over-year, and declined to 11.3% of sales from 14.8%. While SG&A expense benefited from approximately $4.4 million in recoveries related to the favorable outcome of our U.K. patent infringement appeal and a separate favorable settlement of approximately a million dollars, those benefits were largely offset by higher wages and benefits, higher incentive compensation associated with our improved profitability, and incremental expenses related to BMA, the German seat motion company that we acquired in October of last year. Operating income doubled year-over-year to a record $54 million, or 19.9% of sales. While the legal recoveries and settlements contributed to reported results, we also delivered substantial improvement on an adjusted basis with those benefits excluded.
Adjusted operating income was $51 million, also nearly double the prior year level. Adjusted operating margin expanded 650 basis points to 18.8% and reached our stated high teens operating margin target. Interest expense declined approximately $1.1 million, or 37.1%, to $1.8 million, reflecting lower debt balances and the reduction in interest rates following our September 2025 refinancing activities. We recorded a tax benefit of approximately $200,000 in the quarter, which included a partial valuation allowance reversal and research and development credits. In the fourth quarter, we will evaluate whether objectively verifiable evidence of sufficient future taxable income supports an additional release of our deferred tax asset valuation allowance. Depending on that assessment, we could recognize an additional release of approximately $35 million-$40 million.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
8 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
